Sunitinib Reduced the Migration of Ectopic Endometrial Cells via p-VEGFR-PI3K-AKT-YBX1-Snail Signaling Pathway

Endometriosis (EMs) is one of the most common gynecological diseases, lacking effective treatment. EMs are currently being treated with small molecule targeted therapy, which has resulted in a significant reduction in patient suffering. Our previous studies have shown that sunitinib plays an obvious...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaodan Fan, Yanyan Tong, Yiting Chen, Yichen Chen
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2022/6042518
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548793382338560
author Xiaodan Fan
Yanyan Tong
Yiting Chen
Yichen Chen
author_facet Xiaodan Fan
Yanyan Tong
Yiting Chen
Yichen Chen
author_sort Xiaodan Fan
collection DOAJ
description Endometriosis (EMs) is one of the most common gynecological diseases, lacking effective treatment. EMs are currently being treated with small molecule targeted therapy, which has resulted in a significant reduction in patient suffering. Our previous studies have shown that sunitinib plays an obvious role in migration. Consequently, the purpose of this study is to explore the molecular mechanism by which sunitinib suppressed the ectopic endometrial migration. The ectopic endometrial cells from patients were divided into two groups: the control group and the sunitinib group. Co-IP and protein spectrum assay were employed to filtrate differential proteins between two groups, and then, our study discovered a signaling pathway, p-VEGFR-PI3K-AKT-YBX1-Snail, in the cell of EMs. To confirm this signaling pathway, VEGF165 was added to the sunitinib group to upregulate the expression of VEGFR. Next, the expression of p-VEGFR, PI3K, AKT, YBX1, and snail was measured in the control group and sunitinib group (compared with the control group: p-VEGFR, PI3K, AKT, YBX1, and snail, ∗∗∗∗P<0.0001) and the VEGFR+sunitinib group (compared with the sunitinib group: p-VEGFR, PI3K, AKT, and snail, ∗∗∗∗P<0.0001; YBX1, ∗∗∗P<0.001); finally, the outcome was as expected. In addition to in vitro experiments, we also conducted in vivo experiments in mice. In the EMs mouse model, we found sunitinib reduced the number of heterotopic foci (t=11.16, ∗∗∗∗P<0.0001) and inhibited the expression of p-VEGFR, YBX1, and snail by immunofluorescence. To sum up, sunitinib exactly reduced the migration of ectopic endometrial cells with the involvement of the p-VEGFR-PI3K-AKT-YBX1-Snail signaling pathway in both in vitro and in vivo experiments. This study suggests that sunitinib presents a potential targeted drug for EMs therapy.
format Article
id doaj-art-06755eef07684ee6a4d2119c83334ab0
institution Kabale University
issn 2210-7185
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-06755eef07684ee6a4d2119c83334ab02025-02-03T06:13:03ZengWileyAnalytical Cellular Pathology2210-71852022-01-01202210.1155/2022/6042518Sunitinib Reduced the Migration of Ectopic Endometrial Cells via p-VEGFR-PI3K-AKT-YBX1-Snail Signaling PathwayXiaodan Fan0Yanyan Tong1Yiting Chen2Yichen Chen3Ningbo Institute of Medical ScienceNingbo Women and Children’s HospitalNingbo UniversityNingbo Institute of Medical ScienceEndometriosis (EMs) is one of the most common gynecological diseases, lacking effective treatment. EMs are currently being treated with small molecule targeted therapy, which has resulted in a significant reduction in patient suffering. Our previous studies have shown that sunitinib plays an obvious role in migration. Consequently, the purpose of this study is to explore the molecular mechanism by which sunitinib suppressed the ectopic endometrial migration. The ectopic endometrial cells from patients were divided into two groups: the control group and the sunitinib group. Co-IP and protein spectrum assay were employed to filtrate differential proteins between two groups, and then, our study discovered a signaling pathway, p-VEGFR-PI3K-AKT-YBX1-Snail, in the cell of EMs. To confirm this signaling pathway, VEGF165 was added to the sunitinib group to upregulate the expression of VEGFR. Next, the expression of p-VEGFR, PI3K, AKT, YBX1, and snail was measured in the control group and sunitinib group (compared with the control group: p-VEGFR, PI3K, AKT, YBX1, and snail, ∗∗∗∗P<0.0001) and the VEGFR+sunitinib group (compared with the sunitinib group: p-VEGFR, PI3K, AKT, and snail, ∗∗∗∗P<0.0001; YBX1, ∗∗∗P<0.001); finally, the outcome was as expected. In addition to in vitro experiments, we also conducted in vivo experiments in mice. In the EMs mouse model, we found sunitinib reduced the number of heterotopic foci (t=11.16, ∗∗∗∗P<0.0001) and inhibited the expression of p-VEGFR, YBX1, and snail by immunofluorescence. To sum up, sunitinib exactly reduced the migration of ectopic endometrial cells with the involvement of the p-VEGFR-PI3K-AKT-YBX1-Snail signaling pathway in both in vitro and in vivo experiments. This study suggests that sunitinib presents a potential targeted drug for EMs therapy.http://dx.doi.org/10.1155/2022/6042518
spellingShingle Xiaodan Fan
Yanyan Tong
Yiting Chen
Yichen Chen
Sunitinib Reduced the Migration of Ectopic Endometrial Cells via p-VEGFR-PI3K-AKT-YBX1-Snail Signaling Pathway
Analytical Cellular Pathology
title Sunitinib Reduced the Migration of Ectopic Endometrial Cells via p-VEGFR-PI3K-AKT-YBX1-Snail Signaling Pathway
title_full Sunitinib Reduced the Migration of Ectopic Endometrial Cells via p-VEGFR-PI3K-AKT-YBX1-Snail Signaling Pathway
title_fullStr Sunitinib Reduced the Migration of Ectopic Endometrial Cells via p-VEGFR-PI3K-AKT-YBX1-Snail Signaling Pathway
title_full_unstemmed Sunitinib Reduced the Migration of Ectopic Endometrial Cells via p-VEGFR-PI3K-AKT-YBX1-Snail Signaling Pathway
title_short Sunitinib Reduced the Migration of Ectopic Endometrial Cells via p-VEGFR-PI3K-AKT-YBX1-Snail Signaling Pathway
title_sort sunitinib reduced the migration of ectopic endometrial cells via p vegfr pi3k akt ybx1 snail signaling pathway
url http://dx.doi.org/10.1155/2022/6042518
work_keys_str_mv AT xiaodanfan sunitinibreducedthemigrationofectopicendometrialcellsviapvegfrpi3kaktybx1snailsignalingpathway
AT yanyantong sunitinibreducedthemigrationofectopicendometrialcellsviapvegfrpi3kaktybx1snailsignalingpathway
AT yitingchen sunitinibreducedthemigrationofectopicendometrialcellsviapvegfrpi3kaktybx1snailsignalingpathway
AT yichenchen sunitinibreducedthemigrationofectopicendometrialcellsviapvegfrpi3kaktybx1snailsignalingpathway